Literature DB >> 23809388

Double jeopardy.

Damien Cullington1, Natalie Dunford, Stephen Beer, Neil Hobson, Sudipta Chattopadhyay, Joseph John.   

Abstract

Torsades de pointes ("twisting of points") (TdP) is a broad complex tachyarrhythmia which was first described in 1966 by Francois Dessertenne and usually results from prolongation of the QT interval.(1) A wide variety of drugs have been shown to prolong the QT interval in susceptible individuals.(2) We present the case of a former intravenous heroin user presenting with several episodes of TdP which were caused by QT prolongation due to methadone treatment and exacerbated by hepatitis B/C infection. Despite aggressive medical treatment and withdrawal of methadone, he had recurrent episodes of TdP which required continuous temporary cardiac pacing for six days. He was found to have moderate LV dysfunction on his echocardiogram and unobstructed coronary arteries on coronary angiography. He underwent implantation of a defibrillator due to concerns about further episodes of ventricular arrhythmias which could recur even in the absence of further methadone use.
Copyright © 2013 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23809388      PMCID: PMC3861203          DOI: 10.1016/j.ihj.2013.04.016

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  18 in total

Review 1.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

2.  Treatment of torsade de pointes with magnesium sulfate.

Authors:  D Tzivoni; S Banai; C Schuger; J Benhorin; A Keren; S Gottlieb; S Stern
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

3.  [Ventricular tachycardia with 2 variable opposing foci].

Authors:  F Dessertenne
Journal:  Arch Mal Coeur Vaiss       Date:  1966-02

4.  Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.

Authors:  Gerold Mönnig; Julia Köbe; Andreas Löher; Kristina Wasmer; Peter Milberg; Stephan Zellerhoff; Christian Pott; Sven Zumhagen; Razvan Radu; Hans H Scheld; Wilhelm Haverkamp; Eric Schulze-Bahr; Lars Eckardt
Journal:  Europace       Date:  2011-10-06       Impact factor: 5.214

Review 5.  Methadone-induced Torsade de pointes tachycardias.

Authors:  Christian Sticherling; Beat A Schaer; Peter Ammann; Micha Maeder; Stefan Osswald
Journal:  Swiss Med Wkly       Date:  2005-05-14       Impact factor: 2.193

Review 6.  Torsade de pointes: the clinical considerations.

Authors:  Ramesh M Gowda; Ijaz A Khan; Sabrina L Wilbur; Balendu C Vasavada; Terrence J Sacchi
Journal:  Int J Cardiol       Date:  2004-07       Impact factor: 4.164

7.  Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.

Authors:  T A Mattioni; T A Zheutlin; J J Sarmiento; M Parker; M Lesch; R F Kehoe
Journal:  Ann Intern Med       Date:  1989-10-01       Impact factor: 25.391

Review 8.  Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.

Authors:  Ijaz A Khan; Ramesh M Gowda
Journal:  Int J Cardiol       Date:  2004-05       Impact factor: 4.164

9.  Overdrive pacing in quinidine syncope and other long QT-interval syndromes.

Authors:  E DiSegni; H O Klein; D David; C Libhaber; E Kaplinsky
Journal:  Arch Intern Med       Date:  1980-08

10.  Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol.

Authors:  Stefan Kääb; Martin Hinterseer; Michael Näbauer; Gerhard Steinbeck
Journal:  Eur Heart J       Date:  2003-04       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.